Search Within

Tiffany A Traina

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (57)
  2. Journal Article (39)
  3. Review (2)
  4. Guidelines (1)
Groups
  1. Breast Medicine Service (99)
  2. Department of Medicine (99)
  3. Epidemiology and Biostatistics (99)
  4. Solid Tumor Oncology Division (99)
  5. Survivorship Research (99)
  6. Biostatistics Service (85)

More Groups

People
  1. Sujata Patil (62)
  2. Clifford Hudis (53)
  3. Larry Norton (37)
  4. Ayca Gucalp (31)
  5. Chau Dang (25)
  6. Diana Lake (23)

More People

Years
  1. 2024 (8)
  2. 2023 (3)
  3. 2022 (7)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Cancer Research (16)
  3. Breast Cancer Research and Treatment (8)
  4. Annals of Oncology (5)
  5. Clinical Cancer Research (5)
  6. International Journal of Radiation Oncology, Biology, Physics (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. American Association for Cancer Research (21)
  3. Springer (15)
  4. Elsevier Inc. (10)
  5. Oxford University Press (6)
  6. John Wiley & Sons (3)

More Publishers

Results (99)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Poly(ADP-ribose) polymerase (PARP) inhibitors for locally advanced or metastatic breast cancer
    Journal Article

    Khasraw, M.; Patil, S. M.; Traina, T. A.; Robson, M. E.
    Cochrane Database of Systematic Reviews (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • CK14, FOXA1, and androgen receptor (AR) expression in patients (pts) with triple-negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Krasne, M. D.; Jakate, K. A.; Drill, E. N.; Wen, Y. H.; Akram, M.; Ho, A. Y.; Gupta, G. P.; Brogi, E.; Hudis, C. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer
    Journal Article

    Zumsteg, Z. S.; Morrow, M.; Arnold, B.; Zheng, J.; Zhang, Z.; Robson, M.; Traina, T.; McCormick, B.; Powell, S.; Ho, A. Y.
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save
  • Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: A large, single-institution retrospective analysis
    Journal Article

    Perez, C. A.; Zumsteg, Z. S.; Gupta, G.; Morrow, M.; Arnold, B.; Patil, S. M.; Traina, T. A.; Robson, M. E.; Wen, Y. H.; McCormick, B.; more...
    Breast Cancer Research and Treatment (2013)

    Fulltext@MSK | Save